# RES-ACT-QUANTLIB-001-V2 Closeout

Task: `RES-ACT-QUANTLIB-001-V2`
Owner: `Codex`
Reviewer: `Claude`
Status: owner closeout evidence

## Approved Scope

The approved deliverable is adapter-specific QuantLib research activation
evidence:

- `integrations/quantlib/pricing_evidence_retention.md`
- `integrations/quantlib/admission_proof.md`
- focused coverage in `tests/governance/test_quantlib_proof_artifacts.py`

The implementation was merged through PR #316:

- PR: `https://github.com/ajoe734/pantheon/pull/316`
- Task commit: `1195777200cd722e7a51dc2b8672074185384e19`
- Merge commit: `2e72dcfb51b74f89a955b6c336c3c37e7387042c`

Claude approved the reviewed artifacts in
`support/reviews/RES-ACT-QUANTLIB-001-V2-review-claude.md`.

## Owner Verification

Codex re-read the approved artifacts after Claude review approval and confirmed:

- the QuantLib pricing evidence maps to `ProductionDataProof.v1`
- the retained snapshot remains a checksummed, point-in-time TXO option-chain
  research fixture
- the admission proof remains candidate-review only
- `pricing_snapshot`, `evaluation_result`, `registry_admission_packet`, and
  `candidate_packet` are the only allowed output artifact types
- registry write, deployment stage mutation, broker route, runtime binding, and
  capital binding remain explicitly excluded
- no L1 canonical architecture or policy document was changed by this task

Focused verification:

```bash
pytest -q tests/governance/test_quantlib_proof_artifacts.py
```

Result: `5 passed in 0.77s` after merging `origin/dev` into the task branch.

## Closeout Boundary

This closeout records review-approved evidence only. It does not change generic
governance schemas, registry authority, deployment stage policy, broker
execution, runtime binding, or capital binding.
